Mark Holodniy

Publication Details

  • HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance JOURNAL OF CLINICAL VIROLOGY Schirmer, P., Winters, M., Holodniy, M. 2011; 52 (3): 261-264


    We report a case of acute hepatitis B virus genotype A vaccine escape mutant infection with loss of HBV vaccine-induced seropositivity in a HIV-1 infected patient. His HBV is unresponsive to tenofovir/emtricitabine treatment demonstrated by persistent viremia despite lacking known resistance mutations and while having an undetectable HIV-1 viral load.

    View details for DOI 10.1016/j.jcv.2011.07.014

    View details for Web of Science ID 000296556800021

    View details for PubMedID 21840252

Stanford Medicine Resources:

Footer Links: